Cutler Group LLC / CA - AIMMUNE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$10,000
+100.0%
3000.0%0.00%
Q2 2020$5,000
+150.0%
300
-88.5%
0.00%
Q1 2020$2,000
-91.7%
2,600
-54.4%
0.00%
-100.0%
Q4 2019$24,000
-84.4%
5,700
-48.6%
0.00%
-92.9%
Q3 2019$154,000
+470.4%
11,100
+753.8%
0.01%
+366.7%
Q2 2019$27,000
-75.9%
1,300
-93.9%
0.00%
-75.0%
Q1 2019$112,000
+41.8%
21,300
+113.0%
0.01%
+71.4%
Q4 2018$79,000
-70.7%
10,000
-66.9%
0.01%
-63.2%
Q3 2018$270,000
+8900.0%
30,200
+135.9%
0.02%
Q2 2018$3,000
-98.7%
12,800
-68.4%
0.00%
-100.0%
Q1 2018$225,000
+139.4%
40,500
+142.5%
0.02%
+375.0%
Q4 2017$94,000
-54.8%
16,700
-13.0%
0.00%
-42.9%
Q3 2017$208,000
+407.3%
19,200
+43.3%
0.01%
+250.0%
Q2 2017$41,000
-36.9%
13,400
-62.0%
0.00%
-33.3%
Q1 2017$65,000
+85.7%
35,300
+606.0%
0.00%
+200.0%
Q4 2016$35,000
-14.6%
5,000
-25.4%
0.00%0.0%
Q3 2016$41,0006,700
+6600.0%
0.00%
Q2 2016$0100
-96.4%
0.00%
Q1 2016$02,800
+2700.0%
0.00%
Q4 2015$01000.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TLP GROUP LLC 2,904,185$43,563,00046.00%
Foresite Capital Management II, LLC 3,967,900$59,519,00028.42%
Aisling Capital LLC 2,990,000$44,850,0009.24%
Foresite Capital Management III, LLC 935,020$14,025,0006.56%
Vivo Capital, LLC 763,009$11,445,0003.57%
RA Capital Management 1,292,940$19,394,0002.00%
Palo Alto Investors LP 379,727$5,696,0000.33%
EMERALD MUTUAL FUND ADVISERS TRUST 418,214$6,273,0000.32%
EMERALD ADVISERS, LLC 464,364$6,965,0000.31%
Rock Springs Capital Management LP 293,000$4,395,0000.28%
View complete list of AIMMUNE THERAPEUTICS INC shareholders